BSE Live
Feb 27, 15:53Prev. Close
4014.65
Open Price
4014.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 27, 15:57Prev. Close
4015.30
Open Price
4016.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3965.10 (79)
| Balance Sheet of Sanofi India (in Rs. Cr.) | Dec 05 | Dec 04 | |
| 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||
| SHAREHOLDER'S FUNDS | |||
| Equity Share Capital | 23.03 | 23.03 | |
| Total Share Capital | 23.03 | 23.03 | |
| Reserves and Surplus | 483.78 | 380.99 | |
| Total Reserves and Surplus | 500.75 | 398.80 | |
| Total Shareholders Funds | 523.78 | 421.83 | |
| NON-CURRENT LIABILITIES | |||
| Long Term Borrowings | 0.00 | 19.60 | |
| Deferred Tax Liabilities [Net] | 15.71 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 15.71 | 19.60 | |
| CURRENT LIABILITIES | |||
| Short Term Borrowings | 0.00 | 0.00 | |
| Trade Payables | 56.34 | 40.32 | |
| Other Current Liabilities | 28.22 | 57.11 | |
| Short Term Provisions | 86.41 | 32.55 | |
| Total Current Liabilities | 170.97 | 129.98 | |
| Total Capital And Liabilities | 710.46 | 571.41 | |
| ASSETS | |||
| NON-CURRENT ASSETS | |||
| Tangible Assets | 113.74 | 124.90 | |
| Intangible Assets | 26.76 | 26.76 | |
| Capital Work-In-Progress | 1.34 | 2.79 | |
| Other Assets | 0.00 | 0.00 | |
| Fixed Assets | 141.84 | 154.45 | |
| Non-Current Investments | 5.31 | 5.29 | |
| Deferred Tax Assets [Net] | 21.43 | 0.53 | |
| Long Term Loans And Advances | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | |
| Total Non-Current Assets | 168.59 | 160.27 | |
| CURRENT ASSETS | |||
| Current Investments | 0.00 | 0.00 | |
| Inventories | 136.34 | 101.65 | |
| Trade Receivables | 51.03 | 91.82 | |
| Cash And Cash Equivalents | 294.39 | 167.31 | |
| Short Term Loans And Advances | 60.12 | 50.37 | |
| OtherCurrentAssets | 0.00 | 0.00 | |
| Total Current Assets | 541.88 | 411.14 | |
| Total Assets | 710.46 | 571.41 | |
| OTHER ADDITIONAL INFORMATION | |||
| CONTINGENT LIABILITIES, COMMITMENTS | |||
| Contingent Liabilities | 117.07 | 99.62 | |
| CIF VALUE OF IMPORTS | |||
| Raw Materials | 210.55 | 167.80 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | |
| Capital Goods | 0.92 | 0.97 | |
| EXPENDITURE IN FOREIGN EXCHANGE | |||
| Expenditure In Foreign Currency | 4.52 | 16.54 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||
| Dividend Remittance In Foreign Currency | 18.46 | 18.46 | |
| EARNINGS IN FOREIGN EXCHANGE | |||
| FOB Value Of Goods | 222.20 | 192.86 | |
| Other Earnings | 20.34 | 20.40 | |
| BONUS DETAILS | |||
| Bonus Equity Share Capital | 18.38 | 18.38 | |
| NON-CURRENT INVESTMENTS | |||
| Non-Current Investments Quoted Market Value | 5.10 | 1.94 | |
| Non-Current Investments Unquoted Book Value | 5.18 | 5.17 | |
| CURRENT INVESTMENTS | |||
| Current Investments Quoted Market Value | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y